Janssen-Cilag Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Janssen-Cilag Limited - overview

Established

1971

Location

High Wycombe, -, UK

Primary Industry

Pharmaceuticals

About

Based in Buckinghamshire, UK, Janssen-Cilag Limited operates as a pharmaceutical company that develops and markets prescription medicines. It offers a range of prescription medicines and vaccines for diseases in therapeutic areas like oncology, immunology, neuroscience, and infectious diseases. It also provides services related to medical education and information for healthcare professionals.


Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceuticals

Website

https://www.janssen.co.uk

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

Janssen-Cilag Limited - financials

Fiscal Year EndedDec 31, 2017Dec 30, 2018Dec 29, 2019Dec 29, 2020Jan 03, 2021Jan 02, 2022Jan 01, 2023
Revenue (USD)552,543,000621,858,000575,824,000----
% Revenue Growth (YoY)-12.5%(7.4%)----
EBITDA (USD)48,735,00049,132,00053,925,000----
Operating Income (USD)44,043,00043,719,00048,133,000----
Operating Margin8.0%7.0%8.4%----
% EBITDA Margin8.8%7.9%9.4%----
NET Income (USD)35,316,00038,055,00037,556,000----
% Net Margin6.4%6.1%6.5%----
GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.